Skip to main content
. Author manuscript; available in PMC: 2022 Dec 8.
Published in final edited form as: Compr Psychiatry. 2010 Jun 26;52(1):81–87. doi: 10.1016/j.comppsych.2010.04.006

Table 2.

Baseline and posttreatment assessments for GSAD completers of 8 to 12 weeks of paroxetine

Baseline
 Posttreatment
 df t P d
Mean SD Mean SD
GARS 49.1 20.2 24.9 18.1 34 6.0 <.001 1.3
Anxiety 26.4 9.5 14.8 9.3 34 5.6 <.001 1.2
Avoidance 22.6 11.1 10.1 9.7 34 5.9 <.001 1.2
LSAS 77.6 18.9 41.4 25.3 34 8.2 <.001 1.6
SBS 35.0 9.0 26.2 8.7 37 6.3 <.001 1.0
HAM-D 6.9 4.8 3.6 3.6 37 3.4 .002 0.8
BDI 11.6 9.4 5.0 6.0 36 4.9 <.001 0.8

GSAD, generalized social anxiety disorder; GARS, Gaze Anxiety Rating Scale; LSAS, Liebowitz Social Anxiety Scale; SBS, Submissive Behavior Scale; HAM-D, Hamilton Depression Scale; BDI, Beck Depression Inventory.